In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Chequer-board titrations show that the in vitro activity of ciprofloxacin against Mycobacterium tuberculosis is independent of that of streptomycin, isoniazid, ethambutol and pyrazinamide and confirm that there is antagonism between ciprofloxacin and rifampicin.
Uttley
A H
AH
Public Health Laboratory, Dulwich Hospital, London.
Collins
C H
CH
D000995:Antitubercular Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology*; D004977:Ethambutol / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011718:Pyrazinamide / Q000494:pharmacology; D012293:Rifampin / Q000037:antagonists & inhibitors; D013307:Streptomycin / Q000494:pharmacology
D000995:Antitubercular Agents; D011718:Pyrazinamide; D002939:Ciprofloxacin; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin